Colgate-Palmolive (NYSE:CL) Holdings Lifted by AEGON ASSET MANAGEMENT UK Plc

AEGON ASSET MANAGEMENT UK Plc lifted its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 3.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,068,357 shares of the company's stock after acquiring an additional 31,897 shares during the period. Colgate-Palmolive accounts for approximately 1.5% of AEGON ASSET MANAGEMENT UK Plc's portfolio, making the stock its 15th biggest holding. AEGON ASSET MANAGEMENT UK Plc owned 0.13% of Colgate-Palmolive worth $100,006,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at $26,000. Centricity Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at $27,000. Vermillion Wealth Management Inc. acquired a new stake in shares of Colgate-Palmolive during the fourth quarter valued at $31,000. Union Bancaire Privee UBP SA acquired a new stake in Colgate-Palmolive in the 4th quarter worth about $32,000. Finally, Briaud Financial Planning Inc acquired a new stake in Colgate-Palmolive in the 4th quarter worth about $32,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Trading Up 0.0%

Shares of Colgate-Palmolive stock traded up $0.03 on Friday, reaching $90.18. 4,716,460 shares of the company were exchanged, compared to its average volume of 4,712,092. The stock has a fifty day moving average price of $91.77 and a 200-day moving average price of $91.19. The firm has a market capitalization of $73.08 billion, a price-to-earnings ratio of 25.62, a price-to-earnings-growth ratio of 4.20 and a beta of 0.38. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.86 by $0.05. The company had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.92 billion. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. Colgate-Palmolive's revenue for the quarter was down 3.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.86 earnings per share. On average, analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive declared that its Board of Directors has authorized a share repurchase plan on Thursday, March 20th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to buy up to 6.8% of its stock through open market purchases. Stock buyback plans are usually a sign that the company's management believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th were given a dividend of $0.52 per share. The ex-dividend date of this dividend was Thursday, April 17th. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.31%. Colgate-Palmolive's payout ratio is 58.76%.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. Citigroup raised their price target on Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a research note on Monday, April 28th. Barclays decreased their price target on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a research note on Friday, April 11th. UBS Group raised their price target on Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a research note on Thursday, April 17th. Wall Street Zen lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. Finally, JPMorgan Chase & Co. raised their price target on Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a research note on Monday, April 28th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of "Hold" and a consensus target price of $102.12.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.